Zogenix Inc. is a pharmaceutical company engaged in the commercializing and developing products for the treatment of central nervous system disorders and pain.


Updates from The Motley Fool

Latest updates on Zogenix from Fool.com.  The Fool has written over 100 articles on Zogenix.
Why Zogenix Inc. Is Soaring Today

Traders cheer after the company reports positive clinical results. Here's what investors need to ...



Stock Performance

View Interactive ZGNX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Zogenix.
Current Price: $44.37
Prev Close: $43.08
Open: $43.48
Bid: $44.16
Ask: $44.34
Day's Range: $43.16 - $44.77
52wk Range: $33.42 - $62.75
Volume: 193,102
Avg Vol 556,139
Market Cap: $2B
P/E (ttm): -10.91
EPS (ttm): -$3.95
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Zogenix.
CAPS Rating 3 out of 5
 
94 Outperform
15 Underperform
CAPS All Stars
 
13 Outperform
5 Underperform

How do you think Zogenix will perform against the market?



You pick for Zogenix is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Stephen Farr, Ph.D., CEO

100% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Zogenix.

Zogenix Inc. is a pharmaceutical company engaged in the commercializing and developing products for the treatment of central nervous system disorders and pain.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers